SLAMF7重组蛋白，ACROBiosystems百普赛斯

SLAMF7产品信息

英文名称：SLAM family member 7

中文名称：SLAM家族成员-7

靶点别称：SLAMF7,CD319,CS1,CRACC,19A,FOAP-12

物种：Human / Mouse / Rhesus macaque

属性：Protein

标记：Biotin-labeled / FITC Labeled / Unconjugated / PE Labeled

内毒素（Endotoxin）

Less than 1.0 EU per μg by the LAL method.

纯度（Purity）

>95% as determined by SDS-PAGE.

>90% as determined by SEC-HPLC.

制剂（Formulation）

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法（Reconstitution）

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储（Storage）

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

1. -20°C to -70°C for 12 months in lyophilized state;

2. -70°C for 3 months under sterile conditions after reconstitution.

SLAMF7分子背景

SLAM家族成员7（SLAMF7）也被称为CD2样受体激活细胞毒性细胞（CRACC）、膜蛋白FOAP-12、CD抗原CD319、新型Ly9、蛋白19A，它是一种单程I型膜蛋白，是CD2家族细胞表面受体的成员。SLAMF7在脾脏、淋巴结、外周血白细胞、骨髓、小肠、胃、阑尾、肺和气管中表达。SLAMF7的异构体1通过SH2D1A非依赖性细胞外信号调节ERK介导的途径介导NK细胞活化。可能在淋巴细胞粘附中起作用。SLAMF7的异构体3不介导任何NK细胞活化。